Apnimed, Inc. (APMD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Apnimed, Inc. (APMD) closed at USD 17.23 on 2026-10-14, a change of -31.1 % over the past year, with a market capitalization of USD 759.55M.

Apnimed, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Apnimed, Inc. key figures

Previous close

USD 17.23 (2026-10-14)

1-year change

-31.1 %

Market cap

USD 759.55M

Enterprise value

USD 923.07M

P/E ratio (trailing)

2.47

P/E ratio (forward)

-4.59

EPS (trailing)

7.40

EPS (forward)

-3.98

PEG ratio

n/a

Price to book

-0.50

Revenue growth

-29.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.08

Employees

81

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Apnimed, Inc.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Apnimed, Inc. and compare it with other stocks.